Reach Our Drug Product Services Experts:
drugproduct@lonza.com
Lonza’s Drug Product Services team is highly skilled in the development of biopharmaceuticals including standard monoclonal antibodies, recombinant proteins, fusion proteins, antibody-drug-conjugates, and vaccines, as well as viral- and cell-based therapies.
Formulation development services are available for liquid and lyophilized drug product dosage forms and are performed integrating relevant container closure systems such as vials, stoppers and caps or syringes and appropriate drug product process manufacturing designs.
The service offerings comprise the complete array of development activities:
Special expertise is provided for:
The Drug Product Services team works closely with the Drug Substance sites across the Lonza network enabling an integrated and high quality One-Stop-Shop from a single service provider.
All services are available as standalone services.